🕒 Wednesday 15 April 2026 Wed, 15 Apr 2026

Immutep Limited has won FDA Orphan Drug Designation for its immunotherapy eftilagimod alfa in treating soft tissue sarcoma, opening regulatory incentives and potential market exclusivity. This follows encouraging Phase II data despite recent Phase III trial setbacks.

Mesoblast has acquired exclusive rights to a patented chimeric antigen receptor platform designed to enhance the targeting and potency of its mesenchymal stromal cell therapies, aiming to expand treatment options for inflammatory and autoimmune diseases.

Riversgold Limited has reported standout assay results from 31 drill holes at its Northern Zone Gold Project, including a spectacular 71 g/t gold intercept. The campaign expands the shallow gold mineralisation footprint, supporting imminent mining lease conversion and a funding agreement with MEGA Resources.

Larvotto Resources is progressing the Hillgrove Antimony-Gold Project on time and budget, aiming for mid-2026 production amid rising strategic demand for antimony. The project benefits from grid power, ongoing drilling success, and government support for critical minerals.

WhiteHawk Limited has raised A$1.5 million through a share placement to fund integration and growth of its newly acquired Quixxi Clarity AI platform, marking a strategic push into the AI governance market.

Magnum Mining names Antonio Vitor Junior as Managing Director to spearhead major drilling campaigns at its Azimuth and Parker projects, aiming to convert promising early rare earth results into a formal resource.

Xenitra Limited has acquired Hong Kong Fukang Trading Co., including key pharmaceutical licenses and ecommerce assets, to fully operationalise its OTC medicine business in Hong Kong and China.

Strategic Energy Resources has locked in a binding joint venture with Sumitomo Metal Mining Oceania to explore its Bulimba Gold Project in northeast Queensland, with Sumitomo able to earn up to 90% through staged commitments over five years.

Qoria Limited and Aura have pushed back their merger timeline to July 2026 amid transaction complexities, with Aura providing a A$10 million unsecured working capital facility to support Qoria through the interim period.

EV Resources has confirmed a large-scale, shallow carbonate replacement deposit (CRD) antimony system at its Los Lirios project in Mexico, with 10 of 11 drill holes intersecting the mineralised limestone unit. The system extends over a 400m strike and remains open in multiple directions, advancing the company towards a maiden JORC resource estimate.

Iceni Gold’s initial RC drilling at Goose Well confirms historic gold mineralisation and reveals a major fault structure that could unlock broader potential. Diamond drilling is set to refine the geological picture and target high-grade shoots.

Shine Justice reshuffles its top management as Simon Morrison steps down from Managing Director to Executive Director to spearhead international growth, particularly in its burgeoning mass torts program, while Carolyn Barker AM maintains overall CEO leadership.

Wildcat Resources (ASX: WC8) has expanded its Bolt Cutter Central lithium discovery footprint beyond 2.3km with multiple high-grade spodumene intercepts, while advancing the Definitive Feasibility Study for its Tabba Tabba Project. The company maintains a strong cash position of A$43.3 million as it prepares for further drilling and development milestones.

Orthocell has secured approval for its Remplir™ nerve repair device to be used across 221 U.S. military and veterans hospitals, marking a major step in its U.S. commercial expansion. The approval follows clinical validation in conflict zones, positioning Orthocell to deepen penetration into defence healthcare.

Duratec's joint venture with Ertech has clinched a $281 million contract to upgrade submarine infrastructure at HMAS Stirling, marking a major step in Australia's AUKUS defence preparations.

AusQuest gears up for maiden drilling at two promising copper-gold prospects in Peru, aiming to build on the momentum from its Cangallo discovery. Over 8,000 metres of Reverse Circulation drilling are set to test high-priority IOCG and porphyry targets starting Q2 2026.

Cuscal Limited has successfully raised A$30 million through a fully underwritten institutional placement to fund its acquisition of Paymark. The company also launched a Share Purchase Plan targeting an additional A$3 million from eligible shareholders.

Strickland Metals has unveiled an updated Mineral Resource Estimate for its Shanac Deposit in Serbia, now totalling 5.35 million ounces gold equivalent, including a maiden indicated resource of 1.25 million ounces. The resource shows strong grade continuity and remains open for expansion.

Terrain Minerals’ latest drilling at its Lightning Gold Prospect reveals continuous high-grade gold mineralisation, expanding the system’s footprint and complexity. With a mining lease granted and a maiden JORC resource estimate due mid-year, the project is poised for a pivotal phase.

Nyrada has secured ethics approval to start its Phase IIa trial of Xolatryp in heart attack patients, with recruitment beginning in April 2026. The biotech also bolsters its cash position to AU$6.74 million and pursues new oncology indications.

Southern Palladium's latest metallurgical test work from its Bengwenyama PGM Project reveals a doubling in chromite concentrate recoveries and confirms the high-grade nature of its UG2 mineral resource, reshaping project economics and processing design.

Cobre Limited has kicked off a major 40,000-metre drilling campaign at its Sierra Atacama copper project in Chile, aiming to convert its existing NI 43-101 resource to JORC compliance and explore opportunities for a larger open-pit operation.

Cavalier Resources’ 2026 Pre-Feasibility Study update boosts the Stage 1 NPV of its Crawford Gold Project to A$77.2 million at A$6,500/oz gold, reflecting resilience amid supply chain pressures. The project maintains its ore reserve and pit design, with financing negotiations advancing.

Sun Silver has engaged global engineering firm Ausenco to lead critical concept and scoping studies for its Maverick Silver Project in Nevada, aiming to underpin a maiden Scoping Study by late 2026. The move leverages Ausenco’s North American precious metals expertise and comes as silver prices hover near US$77 an ounce, bolstering project economics.